Ouzren Nawal 4

4 · ARENA PHARMACEUTICALS INC · Filed Feb 18, 2021

Form 4

Period: 2021-02-12

Director

Transactions

Award
Common Stock
2021-02-12+893→ 893 total
Award
Common Stock
2021-02-12+595→ 1,488 total
Award
Stock Option (right to buy)
2021-02-12+2,500→ 2,500 total
Exercise: $83.95Exp: 2028-02-12→ Common Stock (2,500 underlying)
Award
Stock Option (right to buy)
2021-02-12+1,666→ 1,666 total
Exercise: $83.95Exp: 2028-02-12→ Common Stock (1,666 underlying)

Footnotes (4)

[F1]The amount represents restricted stock units that vest in three equal installments on the dates of Arena's next three annual meetings of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
[F2]The amount represents restricted stock units that vest in full on the date of Arena's 2021 annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
[F3]The options vest in 36 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over three years beginning on March 12, 2021, and are exercisable once vested.
[F4]The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on March 12, 2021, and are exercisable once vested.

Documents

2 files